Cell engineering Archives

PerkinElmer Picks Up Nexcelom for $260 Million

Acquisitions, Biopharmaceutical, Business, Cell Biology, Cell engineering, Drug Development, Massachusetts, Shares, Tuberculosis

PerkinElmer Inc. expanded the company’s presence in cell biology with the $260 million acquisition of Massachusetts-based Nexcelom Bioscience.

May 14, 2021/by Andrew Humphreys

PerkinElmer Expands Horizons with $383 Million CRISPR Tech Acquisition

Acquisitions, Business, Cell engineering, CRISPR, Gene Editing, Gene modulation, Life Sciences, RNA Interference (RNAi)

Intent on growing PerkinElmer’s life sciences portfolio, the company agreed to acquire cell engineering specialist Horizon Discovery Group for $383 million.

November 3, 2020/by Andrew Humphreys